Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -191.41%-5.27M | -181.46%-2.91M | -121.19%-2.94M | -11.62%-8.11M | -21.80%-3.94M | -78.11%-1.81M | 55.61%-1.03M | -93.30%-1.33M | 7.51%-7.26M | -78.03%-3.23M |
| Net income from continuing operations | -43.34%-3.5M | -60.30%-4.33M | -28.59%-2.77M | -186.87%-11.45M | -124.56%-4.15M | -61.41%-2.44M | -36.23%-2.7M | -768.87%-2.15M | 248.74%13.18M | 5,875.06%16.92M |
| Operating gains losses | -78.87%-533.08K | 619.43%176.16K | 60.67%-81.87K | 43.54%-1.17M | 25.77%-691.36K | -263.39%-298.02K | -50.50%24.49K | 81.31%-208.15K | -17,373.56%-2.08M | -261.41%-931.41K |
| Depreciation and amortization | 1.04%974 | 1.14%979 | 6.39%1.02K | 1.52%3.88K | 2.91%991 | 1.69%964 | 1.79%968 | -0.31%954 | --3.82K | --963 |
| Asset impairment expenditure | ---- | ---- | ---- | 101.72%378.61K | ---- | ---- | ---- | ---- | ---21.99M | ---- |
| Unrealized gains and losses of investment securities | -55.32%-11.02K | -135.99%-11.63K | 61.70%23.55K | 387.87%10.94K | --8.4K | 58.69%-7.1K | -145.80%-4.93K | 68.19%14.57K | -95.23%2.24K | --0 |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -7.68%2.38M | ---- |
| Other non cashItems | 12.57%774.81K | 87.41%745.75K | 37.14%517.12K | -7.36%1.78M | -75.89%318.36K | 226.53%688.28K | 92.29%397.92K | 103.72%377.09K | 251.58%1.92M | 165.88%1.32M |
| Change In working capital | -912.78%-2M | -59.33%507.48K | -198.37%-629.51K | 440.16%2.34M | 121.60%201.93K | -35.65%246.63K | 303.00%1.25M | 33.41%639.93K | -87.74%-686.86K | -1,071.74%-935.03K |
| -Change in receivables | 100.47%20.45K | 439.29%5.53K | -101.49%-371 | 81.98%-6.2K | -13.50%-39.68K | 20.08%10.2K | 32.35%-1.63K | 551.10%24.91K | -425.86%-34.39K | -498.31%-34.96K |
| -Change in prepaid assets | -460.97%-2.48M | -57.64%274.09K | -73.13%149.89K | 145.57%518.84K | 13.54%-243.7K | 41.86%-442.22K | 255.31%647.01K | 73.99%557.75K | -621.73%-1.14M | 23.45%-281.88K |
| -Change in payables and accrued expense | -32.85%455.68K | -62.18%227.86K | -1,460.38%-779.02K | 275.26%1.82M | 178.50%485.31K | -40.22%678.65K | 407.83%602.56K | -65.22%57.27K | 322.27%486.01K | -231.45%-618.2K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -191.41%-5.27M | -181.46%-2.91M | -121.19%-2.94M | -11.62%-8.11M | -21.80%-3.94M | -78.11%-1.81M | 55.61%-1.03M | -93.30%-1.33M | 7.51%-7.26M | -78.03%-3.23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -19.72%-198.17K | 38.37%-118.8K | -573.05%-1.49M | 79.79%-938.38K | -26.01%-359.13K | 96.83%-165.53K | -69.81%-192.75K | -122.42%-220.97K | -189.19%-4.64M | -42.74%-285K |
| Net PPE purchase and sale | --0 | --0 | ---568.14K | 96.48%-136.63K | ---136.63K | --0 | --0 | --0 | -141.56%-3.88M | --0 |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---112.74K | ---- |
| Net other investing changes | -19.72%-198.17K | 38.37%-118.8K | -315.94%-919.11K | -23.00%-801.74K | -29.16%-222.5K | 13.21%-165.53K | -69.00%-192.75K | -26.41%-220.97K | ---651.84K | ---172.26K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -19.72%-198.17K | 38.37%-118.8K | -573.05%-1.49M | 79.79%-938.38K | -26.01%-359.13K | 96.83%-165.53K | -69.81%-192.75K | -122.42%-220.97K | -189.19%-4.64M | -42.74%-285K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 11.87%1.69M | -92.67%40.48K | 11,926.07%17.05M | -23.68%7.78M | -8.54%5.58M | -63.54%1.51M | 1,507.86%552.5K | 141.78K | 14.26%10.2M | 20,068.32%6.1M |
| Net issuance payments of debt | --0 | --0 | --2.05M | 54.90%5.73M | 14.79%4.25M | --1.49M | --0 | --0 | --3.7M | --3.7M |
| Net common stock issuance | --0 | --0 | --15M | --0 | --0 | --0 | --0 | --0 | -67.68%6.5M | 236,153,100.00%2.36M |
| Proceeds from stock option exercised by employees | --1.69M | -92.67%40.48K | --0 | --2.03M | --1.33M | --0 | --552.5K | --141.78K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | --22.91K | --1 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 11.87%1.69M | -92.67%40.48K | 11,926.07%17.05M | -23.68%7.78M | -8.54%5.58M | -63.54%1.51M | 1,507.86%552.5K | --141.78K | 14.26%10.2M | 20,068.32%6.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 1,972.91%10.99M | 1,060.79%13.98M | -48.29%1.35M | -39.52%2.61M | 157.90%64.42K | -75.17%530.11K | -73.92%1.2M | -39.52%2.61M | -10.96%4.32M | -99.60%24.98K |
| Current changes in cash | -711.72%-3.78M | -343.32%-2.99M | 997.21%12.63M | 26.10%-1.26M | -50.28%1.29M | 77.93%-465.69K | 72.84%-673.93K | -571.36%-1.41M | -220.95%-1.71M | 230.28%2.59M |
| End cash Position | 11,089.64%7.21M | 1,972.91%10.99M | 1,060.79%13.98M | -48.29%1.35M | -48.29%1.35M | 157.90%64.42K | -75.17%530.11K | -73.92%1.2M | -39.52%2.61M | -39.52%2.61M |
| Free cash from | -191.41%-5.27M | -181.46%-2.91M | -163.97%-3.51M | 37.34%-8.24M | -26.03%-4.07M | 70.14%-1.81M | 55.60%-1.03M | 13.87%-1.33M | -39.10%-13.16M | -60.39%-3.23M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.